Trials
Search / Trial NCT06444945

Effects of Mulligan Mobilization With Movement as Compared to Kaltenborn Joint Mobilization in the Management of Knee Osteoarthritis

Launched by FOUNDATION UNIVERSITY ISLAMABAD · Jun 5, 2024

Trial Information

Current as of February 19, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Individuals aged 40-70 years (Osama et al, 2022)
  • Having KOA history of no less than 3 months
  • Knee pain less than 8/10 on numeric pain rating scale (NPRS).
  • Radiological evidence of grade III or less on Kellgren classification
  • Patients referred from rehab department
  • Exclusion Criteria:
  • Those with signs of serious pathology, such as malignancy, inflammatory disorder or infection.
  • History of trauma or fractures in lower extremity.
  • Signs of lumbar radiculopathy or myelopathy.
  • History of knee surgery or replacement.
  • Receiving intra-articular steroid therapy in the preceding two months.

Trial Officials

Shanza Fatima, DPT

Principal Investigator

Foundation University Islamabad

Muhammad Osama, PHD*

Principal Investigator

Foundation University Islamabad

About Foundation University Islamabad

Foundation University Islamabad (FUI) is a prominent educational institution dedicated to advancing research and innovation in various fields, including clinical sciences. With a commitment to excellence in education and healthcare, FUI fosters a collaborative environment that encourages multidisciplinary research initiatives. The university actively engages in clinical trials aimed at improving patient outcomes and contributing valuable insights to the medical community. Through its state-of-the-art facilities and a team of experienced professionals, Foundation University Islamabad strives to uphold the highest ethical standards in clinical research, ensuring the integrity and reliability of its findings.

Locations

Islamabad, , Pakistan

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0